His primary areas of investigation include Surgery, Hepatectomy, Internal medicine, Liver transplantation and Gastroenterology. His research links Cancer with Surgery. The Hepatectomy study combines topics in areas such as Preoperative care, Survival rate, Rectum, Contraindication and Colorectal cancer.
Internal medicine is represented through his Cirrhosis, Hepatocellular carcinoma and Mortality rate research. Liver transplantation is a subfield of Transplantation that Daniel Azoulay investigates. As a member of one scientific family, Daniel Azoulay mostly works in the field of Gastroenterology, focusing on Proportional hazards model and, on occasion, Confidence interval.
Surgery, Liver transplantation, Internal medicine, Gastroenterology and Hepatectomy are his primary areas of study. Daniel Azoulay integrates many fields in his works, including Surgery and In patient. To a larger extent, he studies Transplantation with the aim of understanding Liver transplantation.
Hepatocellular carcinoma, Cancer, Chemotherapy and Hepatology are the primary areas of interest in his Internal medicine study. His Hepatocellular carcinoma study incorporates themes from Cirrhosis and Carcinoma. Daniel Azoulay has included themes like Contraindication, Colorectal cancer, Metastasis and General surgery in his Hepatectomy study.
Daniel Azoulay focuses on Surgery, Internal medicine, Liver transplantation, Hepatectomy and Hepatocellular carcinoma. In his work, Operative time is strongly intertwined with General surgery, which is a subfield of Surgery. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology.
His Liver transplantation study combines topics in areas such as Ligation, Complication, Proportional hazards model, Hazard ratio and Inferior vena cava. His Hepatectomy research incorporates themes from Survival rate, Carcinoma and Meta-analysis. His Hepatocellular carcinoma study combines topics from a wide range of disciplines, such as Stage, Cirrhosis, Radiofrequency ablation and Prospective cohort study.
The scientist’s investigation covers issues in Surgery, Hepatocellular carcinoma, Liver transplantation, Internal medicine and Hepatectomy. His research on Surgery often connects related areas such as General surgery. His Hepatocellular carcinoma research is multidisciplinary, incorporating elements of Liver disease and Positron emission tomography, Nuclear medicine.
His research integrates issues of Cirrhosis, Liver function tests and Intention-to-treat analysis in his study of Liver transplantation. His research in Internal medicine intersects with topics in Gastroenterology and Cardiology. Daniel Azoulay has researched Hepatectomy in several fields, including Odds ratio, Carcinoma, Meta-analysis and Survival rate.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.
René Adam;Valérie Delvart;Gérard Pascal;Adrian Valeanu.
Annals of Surgery (2004)
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?
René Adam;Gerard Pascal;Denis Castaing;Daniel Azoulay.
Annals of Surgery (2004)
Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases
R. Adam;E. Avisar;A. Ariche;S. Giachetti.
Annals of Surgical Oncology (2001)
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.
René Adam;Alexis Laurent;Daniel Azoulay;Denis Castaing.
Annals of Surgery (2000)
Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.
Daniel Azoulay;Denis Castaing;Alloua Smail;René Adam.
Annals of Surgery (2000)
Liver Histology and Surgical Outcomes After Preoperative Chemotherapy With Fluorouracil Plus Oxaliplatin in Colorectal Cancer Liver Metastases
Thomas A Aloia;Mylène Sebagh;Marylène Plasse;Vincent Karam.
Journal of Clinical Oncology (2006)
Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.
Pietro E. Majno;René Adam;Henri Bismuth;Denis Castaing.
Annals of Surgery (1997)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux;Françoise Roudot-Thoraval;Thomas Decaens;Fabienne Pessione.
Gastroenterology (2012)
Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?
René Adam;Dennis A. Wicherts;Robbert J. de Haas;Oriana Ciacio.
Journal of Clinical Oncology (2009)
Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver.
Daniel Azoulay;Denis Castaing;Jinane Krissat;Alloua Smail.
Annals of Surgery (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Inserm : Institut national de la santé et de la recherche médicale
University of Paris-Saclay
University of Paris-Saclay
Université Paris Cité
Inserm : Institut national de la santé et de la recherche médicale
University of Paris-Saclay
Université Paris Cité
Beaujon Hospital
The Ohio State University Wexner Medical Center
Yale University
Stony Brook University
Florida State University
Kyoto University
Max Planck Society
School for Advanced Research
National Institute of Advanced Industrial Science and Technology
Woods Hole Oceanographic Institution
Helmholtz Centre for Environmental Research
Agricultural Research Service
Chinese Academy of Sciences
University of Eastern Finland
Mayo Clinic
University of Massachusetts Medical School
National Institutes of Health
University of Iowa